Juvena Therapeutics Raises $41M in Series A Funding

November 8, 2022

Juvena Therapeutics, a Redwood City, CA-based biotechnology company, raised $41M in Series A funding.

The round was led by Mubadala Capital and Horizons Ventures, with participation from Bison Ventures, Manta Ray Ventures, IRONGREY, Alumni Ventures, Plum Alley, Jeff Dean, Transform VC, Karl Pfleger, BoxOne Ventures, Intersect VC, Compound, and Felicis.

The company intends to use the funds for the expansion of its drug discovery platform and advance its biologics pipeline targeting chronic and age-related diseases.